Page last updated: 2024-11-03

opc 12759 and Keratoconjunctivitis

opc 12759 has been researched along with Keratoconjunctivitis in 2 studies

rebamipide: structure in first source; RN refers to (+-)-isomer; inhibits gastric xanthine oxidase

Keratoconjunctivitis: Simultaneous inflammation of the cornea and conjunctiva.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Takahashi, Y1
Ichinose, A1
Kakizaki, H1
Arakaki, R1
Eguchi, H1
Yamada, A1
Kudo, Y1
Iwasa, A1
Enkhmaa, T1
Hotta, F1
Mitamura-Aizawa, S1
Mitamura, Y1
Hayashi, Y1
Ishimaru, N1

Other Studies

2 other studies available for opc 12759 and Keratoconjunctivitis

ArticleYear
Topical rebamipide treatment for superior limbic keratoconjunctivitis in patients with thyroid eye disease.
    American journal of ophthalmology, 2014, Volume: 157, Issue:4

    Topics: Administration, Topical; Adult; Aged; Alanine; Antioxidants; Female; Fluorescein; Fluorescent Dyes;

2014
Anti-inflammatory effects of rebamipide eyedrop administration on ocular lesions in a murine model of primary Sjögren's syndrome.
    PloS one, 2014, Volume: 9, Issue:5

    Topics: Administration, Ophthalmic; Alanine; Animals; Anti-Inflammatory Agents; Cells, Cultured; Disease Mod

2014